Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
| dc.contributor.author | Hanwella, Raveen | |
| dc.contributor.author | Wijesundera, H. | |
| dc.contributor.author | De Silva, V.A. | |
| dc.date.accessioned | 2025-11-12T08:42:50Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Many studies have shown that the prevalence of smoking in schizophrenia is higher than in the general population. Biological, psychological and social factors influence smoking in patients with schizophrenia. Methods: The study was carried out in psychiatry outpatient clinics in a tertiary care hospital in Sri Lanka. Every third patient was selected using systematic sampling from patients diagnosed with schizophrenia according to ICD-10 clinical criteria. Smoking behaviours were assessed using self-reports. Severity of illness was assessed using Brief Psychiatric Rating Scale (BPRS). Fagerstrom Test for Nicotine Dependence assessed level of dependence. Readiness to Change Questionnaire assessed motivation to change smoking behaviour. | |
| dc.identifier.citation | Wijesundera, H., Hanwella, R. & de Silva, V.A. Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study. Ann Gen Psychiatry 13, 7 (2014). https://doi.org/10.1186/1744-859X-13-7 | |
| dc.identifier.uri | https://doi.org/10.1186/1744-859X-13-7 | |
| dc.identifier.uri | https://archive.cmb.ac.lk/handle/70130/8149 | |
| dc.language.iso | en | |
| dc.publisher | Springer Nature | |
| dc.subject | Nicotine | |
| dc.subject | Schizophrenia | |
| dc.subject | Clozapine | |
| dc.subject | Olanzapine | |
| dc.title | Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study | |
| dc.type | Article |
